Individualizing the radiotherapy target volume for glioblastoma using DTI-MRI: a phase 0 study on coverage of recurrences

Autor:	Slavka Lukacova, Jesper F. Kallehauge, Morten B. Jensen, Anouk K. Trip
Rok vydání:	2019
Předmět:	medicine.medical_specialty endocrine system diseases business.industry medicine.medical_treatment Malignant brain tumor Dose fractionation Planning target volume Hematology General Medicine medicine.disease behavioral disciplines and activities nervous system diseases Radiation therapy Clinical trial nervous system Oncology medicine Radiology Nuclear Medicine and imaging Progression-free survival Radiology business neoplasms Glioblastoma Diffusion MRI
Zdroj:	Trip, A K, Jensen, M B, Kallehauge, J F & Lukacova, S 2019, ' Individualizing the radiotherapy target volume for glioblastoma using DTI-MRI : a phase 0 study on coverage of recurrences ', Acta Oncologica, vol. 58, no. 10, pp. 1532-1535 . https://doi.org/10.1080/0284186X.2019.1637018
ISSN:	1651-226X 0284-186X
DOI:	10.1080/0284186x.2019.1637018
Popis:	Glioblastoma (GBM) is the most aggressive malignant brain tumor leading to a dismal prognosis. The median overall survival (OS) is only 15 months despite extensive tri-modality treatment. The curre...
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::248e5ba162af4bc23df82552f74c90ac https://doi.org/10.1080/0284186x.2019.1637018 Zobrazit plný text záznamu Plný text ve formátu PDF Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.